Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1996 2
1997 3
1998 2
1999 3
2000 3
2006 1
2007 1
2008 2
2009 2
2010 2
2011 2
2012 1
2014 1
2018 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO; EUVAS (European Vasculitis Study Group). de Groot K, et al. Ann Intern Med. 2009 May 19;150(10):670-80. doi: 10.7326/0003-4819-150-10-200905190-00004. Ann Intern Med. 2009. PMID: 19451574 Clinical Trial.
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
Harper L, Morgan MD, Walsh M, Hoglund P, Westman K, Flossmann O, Tesar V, Vanhille P, de Groot K, Luqmani R, Flores-Suarez LF, Watts R, Pusey C, Bruchfeld A, Rasmussen N, Blockmans D, Savage CO, Jayne D; EUVAS investigators. Harper L, et al. Ann Rheum Dis. 2012 Jun;71(6):955-60. doi: 10.1136/annrheumdis-2011-200477. Epub 2011 Nov 29. Ann Rheum Dis. 2012. PMID: 22128076 Clinical Trial.
[Diabetic nephropathy].
Chábová V. Chábová V. Cas Lek Cesk. 1997 Nov 19;136(22):683-8. Cas Lek Cesk. 1997. PMID: 9476379 Review. Czech.
[Rhabdomyolysis and acute renal failure].
Chábová V, Tesar V, Lachmanová J, Zima T. Chábová V, et al. Cas Lek Cesk. 1993 Dec 6;132(23):705-8. Cas Lek Cesk. 1993. PMID: 8293439 Review. Czech.
Long term treatment of IgA nephropathy with cyclosporine A.
Chábová V, Tesar V, Zabka J, Rychlik I, Merta M, Jirsa M Jr, Stejskalová A. Chábová V, et al. Ren Fail. 2000 Jan;22(1):55-62. doi: 10.1081/jdi-100100851. Ren Fail. 2000. PMID: 10718281 Free article. Clinical Trial.
20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Sedláková L, Kikerlová S, Husková Z, Červenková L, Chábová VČ, Zicha J, Falck JR, Imig JD, Kompanowska-Jezierska E, Sadowski J, Krátký V, Červenka L, Kopkan L. Sedláková L, et al. Among authors: chabova vc. Biosci Rep. 2018 Sep 12;38(5):BSR20171496. doi: 10.1042/BSR20171496. Print 2018 Oct 31. Biosci Rep. 2018. PMID: 30054426 Free PMC article.
29 results